Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Detection of Ocular Surface Squamous Neoplasia Using Artificial Intelligence with High-Resolution Anterior Segment Optical Coherence Tomography
Author Affiliations & Notes
  • Jason Greenfield
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Rafael Scherer
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Diego Alba
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Sofia De Arrigunaga
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Osmel Alvarez
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Sotiria Palioura
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Afshan Nanji
    Oregon Health & Science University, Portland, Oregon, United States
  • Ghada Al Bayyat
    Government Hospitals, Manama, Bahrain
  • Douglas Costa
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • William Herskowitz
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Michael Antonietti
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Alessandro Jammal
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Anat Galor
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Department of Ophthalmology and Visual Sciences, Miami Veterans Administration Medical Center, Miami, Florida, United States
  • Felipe Medeiros
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Carol Karp
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Jason Greenfield None; Rafael Scherer None; Diego Alba None; Sofia De Arrigunaga None; Osmel Alvarez None; Sotiria Palioura None; Afshan Nanji None; Ghada Al Bayyat None; Douglas Costa None; William Herskowitz None; Michael Antonietti None; Alessandro Jammal None; Anat Galor PCT/US2022/029842, Code P (Patent); Felipe Medeiros AbbVie, Annexon, Astellas, Carl Zeiss Meditec, Galimedix, ONL Therapeutics, Perfusion Therapeutics, Stealth Biotherapeutics, Stuart Therapeutics, Thea Pharmaceuticals, Reichert, Code C (Consultant/Contractor), Google Inc., Heidelberg Engineering, Novartis, Reichert, Code F (Financial Support), nGoggle Inc., Code P (Patent); Carol Karp Interfeen Biologics, Glaukos, Code C (Consultant/Contractor), PCT/US2022/029842, Code P (Patent)
  • Footnotes
    Support  Research to Prevent Blindness Medical Student Eye Research Fellowship Award, Singerman and Schwartz Medical Student Research Scholarship
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4093. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jason Greenfield, Rafael Scherer, Diego Alba, Sofia De Arrigunaga, Osmel Alvarez, Sotiria Palioura, Afshan Nanji, Ghada Al Bayyat, Douglas Costa, William Herskowitz, Michael Antonietti, Alessandro Jammal, Anat Galor, Felipe Medeiros, Carol Karp; Detection of Ocular Surface Squamous Neoplasia Using Artificial Intelligence with High-Resolution Anterior Segment Optical Coherence Tomography. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4093.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop and validate a deep learning (DL) model to differentiate ocular surface squamous neoplasia (OSSN) from clinically confounding conditions, such as pterygium and pinguecula, using high resolution anterior segment optical coherence tomography (HR-OCT) images.

Methods : Imaging data was extracted from Optovue HR-OCT (Fremont, CA) and subjects’ clinical or biopsy-proven diagnoses were collected from electronic medical records. A DL classification model was developed using two methodologies: (1) an autoencoder model was trained with unlabeled data from 84,687 HR-OCT images of 5892 eyes to reduce the image into a low-dimensional latent space, and (2) a Vision Transformer supervised model (ViT) used labeled data as an input for fine-tuning a binary classifier (OSSN vs. non-OSSN lesions). A sample of 435 eyes from 308 subjects (1,223 HR-OCT) images were classified by expert graders into “OSSN or suspicious for OSSN” and “pterygium or pinguecula”. The best performing algorithm was selected using the accuracy of the validation dataset. The algorithm's diagnostic performance was then assessed in a separate test sample using 679 scans (85 eyes, 48 subjects) with biopsy-proven OSSN. Analysis was conducted at the patient level and, for the DL model, an eye was classified as having OSSN if at least one scan was positive for OSSN.

Results : The model had an accuracy of 91.7% (95%CI: 80.0-97.7%), with sensitivity of 90.9% (95%CI: 70.8-98.9%) and specificity of 92.3% (95%CI: 74.9-99.1%). The area under the receiver operating characteristic curve (AUC) was 0.916 (95%CI: 0.835-0.997) for the best performing DL model at the patient level. Human gradings had lower performance than the DL model (AUC=0.687, P=0.003) at the patient level, with sensitivity of 68.2% (95%CI: 45.1-86.1) and specificity of 69.2% (95% CI: 48.2-85.7%).

Conclusions : A DL model, applied to HR-OCT scans of the anterior segment, demonstrated high accuracy in differentiating OSSN from similar clinical conditions such as pterygium and pinguecula. Interestingly, the model surpassed the diagnostic performance of clinicians in this study and shows promise for enhancing clinical decision-making. Further research is warranted to explore the integration of this AI-driven approach in routine screening and diagnostic protocols for OSSN.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×